Clinical Trial Update: Study Evaluating Efficacy and Safety of Crisaborole in Adults With Stasis Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating efficacy and safety of Crisaborole in adults with Stasis Dermatitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stasis Dermatitis

Drugs mentioned

• Crisaborole (crisaborole)

Snippet

Sponsor: Pfizer | Conditions: Stasis Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2022-05-02